Psoriasis

Plaque severity increases neutrophil levels and aortic vascular inflammation.  

An overview of the use, safety, and efficacy of the PDE4 inhibitor apremilast, a promising new systemic therapy for treating psoriatic disease.  

Outcomes after hip replacement surgery are as good in patients with psoriatic arthritis or cutaneous psoriasis as in patients with OA; surgeons should not avoid offering replacement surgery as needed.  

Enstilar combines calcipotriene and betamethasone dipropionate in a foam formulation for topical treatment of plaque psoriasis in adults.  

Following the recent surveillance review which checks the need to update CG153, this guideline should not be updated at this time. This guideline will be checked again for update at its scheduled time point according to the methods described here.